Login to Your Account

37 biotechs complete IPOs, raise $3B

Argos and Eleven file last IPOs of 2013

By Catherine Shaffer
Staff Writer

Thursday, January 2, 2014

Two biotech companies, Argos Therapeutics Inc. and Eleven Biotherapeutics Inc., slid initial public offering (IPO) filings under the wire for 2013 to raise $60 million and $69 million, respectively. The filings cap a spectacular year for IPOs. Thirty-seven biotechs successfully completed IPOs in 2013, raising about $3 billion. Argos and Eleven will join 15 other companies filed and pending for 2014.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription